Lexicon Pharmaceuticals, Inc. Reports 2008 First Quarter Financial Results
THE WOODLANDS, Texas, April 29, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2008.